Novacyt SA (ALNOV) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB −0,32%	1 100,57	−3,53	−0,32%	—	1 104,10	1 103,92	1 108,75	1 097,16	—	—
SIXC Communications SIXC Communications	SIXC +0,16%	605,15	+0,99	+0,16%	—	604,16	604,16	610,19	604,12	—	—
SIXE Energy SIXE Energy	SIXE −0,22%	1 195,19	−2,62	−0,22%	—	1 197,81	1 200,58	1 213,07	1 192,02	—	—
SIXI Industrials SIXI Industrials	SIXI −0,03%	1 739,91	−0,50	−0,03%	—	1 740,41	1 739,55	1 750,27	1 730,60	—	—
SIXM Financials SIXM Financials	SIXM +0,65%	638,56	+4,12	+0,65%	—	634,44	633,13	639,87	633,01	—	—
SIXR Staples SIXR Staples	SIXR −1,11%	831,57	−9,33	−1,11%	—	840,90	839,53	841,73	831,10	—	—
SIXRE Real estate SIXRE Real estate	SIXRE −0,82%	213,36	−1,77	−0,82%	—	215,13	215,13	215,85	213,24	—	—
SIXT Technology SIXT Technology	SIXT +0,17%	3 234,18	+5,47	+0,17%	—	3 228,71	3 225,62	3 235,43	3 198,95	—	—
SIXU Utilities SIXU Utilities	SIXU −0,02%	935,65	−0,22	−0,02%	—	935,87	938,37	942,00	935,65	—	—
SIXV Health care SIXV Health care	SIXV −0,54%	1 449,26	−7,86	−0,54%	—	1 457,12	1 452,74	1 466,88	1 449,18	—	—
SIXY Discretionary SIXY Discretionary	SIXY −0,72%	2 382,45	−17,39	−0,72%	—	2 399,84	2 389,71	2 394,61	2 371,22	—	—

ALNOV:EPA

Novacyt SA

0,36 €

−1,92%

(−0,0070) 1 D

28. apr., 14:53:10 GMT+2 · EUR

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for ALNOV …

Åpne

0,36 €

Høy

0,36 €

Lav

0,36 €

Markedsverdi

26,27 mill.

Snittvolum

113,27k

Volum

74,00k

52 u høy

0,74 €

52 u lav

0,36 €

EPS

−0,50 €

Utestående aksjer

72,59 mill.

Antall ansatte

234

Relaterte aksjer

Ose Immunotherapeutics SA

Nyhetssaker

Fra kilder på nettet

Stock Titan

for 15 minutter siden

Credit Acceptance (NASDAQ: CACC) 2026 proxy outlines 10-year CEO RSU plan

Seeking Alpha

for 27 minutter siden

4 Mutual Funds Retirees May Be Missing That Have Outperformed the S&P 500 (NYSEARCA:SPY)

Nasdaq

for 27 minutter siden

On the Ground: Key Takeaways from Nasdaq Capital Market Forum in Stockholm

PR Newswire

for 32 minutter siden

NYSE Content Update: Joby Aviation Rings Opening Bell Following NYC Test Flight

Profil

Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare. In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia

Om Novacyt SA

Administrerende direktørDavid Allmond

Ansatte234

Grunnlagt3. juli 2006

Hovedkontor-

Sektor-

Nettstednovacyt.com

Alle verdier i GBP	sep. 2024	des. 2024	mars 2025	juni 2025
Inntekt	-	-	4,90 mill.	4,90 mill.
Varekostnad	-	-	1,64 mill.	1,64 mill.
Direkte driftskostnader	-	-	1,64 mill.	1,64 mill.
Utgifter til forskning og utvikling	-	-	1,02 mill.	1,02 mill.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	-	-	5,51 mill.	5,51 mill.
Driftskostnader	-	-	6,43 mill.	6,43 mill.
Totale driftskostnader	-	-	8,08 mill.	8,08 mill.
Driftsinntekter	-	-	−3,18 mill.	−3,18 mill.
Andre ikke-operasjonelle inntekter	-	-	−31,00k	−31,00k
EBT inkludert uvanlige elementer	-	-	−3,51 mill.	−3,51 mill.
EBT uten uvanlige elementer	-	-	−3,12 mill.	−3,12 mill.
Kostnad for inntektsskatt	-	-	−133,50k	−133,50k
Faktisk avgiftssats	-	-	3,80 %	3,80 %
Andre driftskostnader	-	-	−97,50k	−97,50k
Nettoinntekt	-	-	−3,17 mill.	−3,17 mill.
Netto fortjenestemargin	-	-	−64,76 %	−64,76 %
Resultat per aksje	-	-	-	-
Rente- og investeringsinntekter	-	-	177,00k	177,00k
Rentekostnader	-	-	−154,00k	−154,00k
Netto rentekostnader	-	-	23,00k	23,00k
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	-	-	−2,17 mill.	−2,17 mill.
Gevinst eller tap ved salg av eiendeler	-	-	−147,50k	−147,50k

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning